Current schizophrenia drugs: efficacy and side effects. (Record no. 16320442)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01239 a2200349 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250515025941.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 200710s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1744-7666 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1517/14656566.7.8.1005 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Krebs, Michael |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20071026 |
245 00 - TITLE STATEMENT | |
Title | Current schizophrenia drugs: efficacy and side effects. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Expert opinion on pharmacotherapy |
Date of publication, distribution, etc. | Jun 2006 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 1005-16 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Comparative Study; Journal Article; Review |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antipsychotic Agents |
General subdivision | adverse effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Basal Ganglia Diseases |
General subdivision | etiology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Cognition |
General subdivision | drug effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Long QT Syndrome |
General subdivision | etiology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Patient Compliance |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Quality of Life |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Schizophrenia |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Secondary Prevention |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Weight Gain |
General subdivision | drug effects |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Leopold, Karolina |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Hinzpeter, Axel |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Schaefer, Martin |
773 0# - HOST ITEM ENTRY | |
Title | Expert opinion on pharmacotherapy |
Related parts | vol. 7 |
-- | no. 8 |
-- | p. 1005-16 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1517/14656566.7.8.1005">https://doi.org/10.1517/14656566.7.8.1005</a> |
Public note | Available from publisher's website |
No items available.